About us
More than just a consultant, ExpandPharma will be an extension of your company in Turkey by working as a part of your team and acting on your behalf.
ExpandPharma provides an integrated suite of services and solutions for pharmaceutical companies from strategy to execution.
With a growing population of 85 million, the implementation of universal healthcare coverage, it's competitive location and strong export network, Turkey is one of the world's most promising pharmaceutical markets.
Established in 2014 in İstanbul, ExpandPharma Consulting provides a portfolio of tailor-made solutions to pharmaceutical companies to realize the full potential of their products in Turkey.
- Understand healthcare ecosystem
- Find many collaboration and partnership opportunities
- Get your products on the market much faster
Our Services
We offer range of Consultancy Services
Read More
Market Access
Giving strategic advice for all the market access options available in Turkey
Learn More
Read More
Regulatory Affairs
Ensuring regulatory compliance and optimizing the time to obtain approval of the products in Turkey
Learn More
Business Development
We offer help for Turkey Market Entry Solutions
The pharmaceutical market in Turkey is one of the largest and fastest growing markets in the Middle East and North Africa region. With a population of more than 80 million, Turkey offers a large and diverse market for pharmaceutical products.
Global pharmaceutical companies are headquartered in Turkey with significant manufacturing operations using Turkey as a hub for access to regional markets. Successful partnerships are formed with local companies to grow in the region, leveraging the experience and networks of local people.
Turkey is a candidate to be one of the global pharma leaders with its competitive position and export network.
We offer help for the following Market Entry Solutions
Foreign subsidiary establishment
Establishment of the local legal entity in Turkey, which is required to have marketing authorization for pharmaceutical products.
- Setting up an office/legal entity with a min. cost
- Market research, competitive analysis and initial sales forecasting
- Regulatory Affairs and Market Access management
- Establishing pharmacovigilance system
- Assessment of vendors when needed (like 3PL, translation agent, customs agent, financial advisor, contract pharmacovigilance service provider etc.)
Distributorship agreements
Distributorship agreements with local companies for licensing, sale and distribution of the products.
- Search for potential partners in Turkey for the chosen products
- Arrangement of meetings with potential partners
- Assisting in contract negotiations
- Providing guidance during the implementation phase
Strategic Alliance
Co-development, contract manufacturing, out-licensing and in-licensing deals with Turkish companies.
- Getting in contact with the potential partners
- Arranging and conducting on-site visits
- Assisting in contract negotiations
- Providing guidance during the implementation phase
Market Access
Giving strategic advice for all the market access options available in Turkey
Market access includes generating and communicating data for stakeholders involved in drug adoption and financing, and ensuring that products are priced and reimbursed fairly.
Assessing the burden of disease, sizing the market, developing appropriate pricing, measuring the regulatory and policy environment and implementing the most appropriate distribution approach are the major subjects.
Market access options available in Turkey:
- Applying for marketing authorisation
- Named patient programme
- Compassionate use programme
Our services for Market Access Options
Market Assessment
Initial market assessment helps with undestanding market and competition.
- Market landscape analysis
- Competitor analysis
- Pricing and Positioning Analysis
- Key Opinion Leader Surveys
Pricing
Points to be considered in pricing in Turkey are government's pricing policies and restrictions, currency fluctuations, customers' solvency, the nature of competition and market entry mode.
- Determining the optimum price level for the products according to local regulations and competition in the market
Reimbursement
In Turkey, most of the prescribed drugs are included in the Social Security Institution (“SSI”) reimbursement list, and the payments for the treatments are fully or partially paid by the SSI. The national health insurance covers more than 98% of the overall population.
- Developing scenarios to discover the right access path at country level.
- Preparation of a Turkey specific pharmacoeconomic evaluation and application dossier for reimbursement approval.
Regulatory Affairs
Ensuring regulatory compliance and optimizing the time to obtain approval of the products in Turkey
We provide following services for Marketing Authorization Applications:
- Preparation of registration dossiers in eCTD format and according to country specific requirements
- Preparation and revision of national SPC, PIL and labelling
- Preparation of application dossiers for Marketing Authorization Transfer
- Giving advice and assistance for compliance with the local requirements
Recent Posts
Here is the latest company posts
